Carlos Tortely Hospital
Niterói, 20231-048, Brazil
NCT Number: NCT05779085
A clinical study with 56 healthy subjects (both sexes) aged between 13 to 25 years old. Subjects enrolled had a minimum of 5 inflammatory lesions (papules, nodules and pustules) and 10 non-inflammatory lesions (open and closed comedones), determined by dermatologist. The clinical evaluation considered in oiliness, shininess and global aspect of the skin too. Instrumental assessment of oiliness and shininess was performed, respectively, by Sebumeter and Sebutape.
IThe tested cleanser was used twice daily (morning and evening) during 28 days.
Looking for future studies?
Notify Me13 year–26 year
All sexes
Observational
Niterói, 20231-048, Brazil
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of daily cleanser to treat facial acne
Other names: Cleanser
Time frame: baseline
using GEA scale
Time frame: Day 28
using GEA scale
Time frame: baseline
count
Time frame: Day 28
count
Time frame: baseline
count
Time frame: Day 28
count
Time frame: baseline
instrumental measurement Sebumeter
Time frame: Day 28
instrumental measurement Sebumeter
Time frame: baseline
instrumental measurement Sebumeter
Time frame: Day 28
instrumental measurement Sebumeter
Time frame: Day 28
questionnaire
Cosmetique Active International
Industry
ASSESSMENT OF CLINICAL, INSTRUMENTAL AND NOTICED EFICACY BY SUBJECTS OF A COSMETIC PRODUCT 12.0417.01.090 UNDER NORMAL CONDITIONS OF USE Study With Dermatological Follow-up Including Instrumental Measurements
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07357337
Acne Vulgaris, Acne Vulgaris on the Face
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06729450
Acne Vulgaris, Acne Vulgaris on the Face
Miami, Florida, United States
View Trial DetailsNCT06905210
Acne Vulgaris, Acne Vulgaris on the Face
Itapevi, São Paulo, Brazil
View Trial Details